Abstract
[No abstract available in the source PDF. First paragraph follows.] before Primary Percutaneous Coronary Intervention. Nat Cell Sci 2024;2(3):204–205. doi: 10.61474/ncs.2024.00021. Catheterization-associated acute kidney injury, commonly referred to as contrast-induced nephropathy (CIN), remains a significant complication after contrast-involving cardiac procedures.1 Despite the substantial improvement in the current iodinated contrast formulations, the incidence of CIN still ranges between 1% and 25% in routine coronary practice, depending on the characteristics of the studied population. 1,2 ST-elevation myocardial infarction (STEMI) remains one of the most critical and time-sensitive cardiac emergencies, where minimizing delays and prioritizing prompt revascularization, ideally through primary percutaneous coronary intervention (pPCI), is paramount.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2024 Nature Cell and Science

